Clinical Trial: A Single-Arm, Open-Label Phase II Clinical Trial to Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined with NBB-001 and NBB-002 for Patients with Recurrent Head and Neck Malignancies (China)

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Arm, Open-Label Phase II Clinical Trial to Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined with NBB-001 and NBB-002 for Patients with Recurrent Head and Neck Malignancies'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130508

Registration Time: 2026/08/20

Type: Interventional study

Primary Sponsor: Xiamen Humanity Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338102

Published by HT Digital Content Services with permission from Health Daily Digest....